FilingReader Intelligence
Wantai Bio uses idle funds for cash management
May 8, 2025 at 05:09 PM UTC•By FilingReader AI
Beijing Wantai Biological Pharmacy Enterprise (SSE:603392) announced it is using part of its idle raised funds for cash management. The company allocated CNY 69.15 million to a 7-day notice deposit with Shanghai Pudong Development Bank, with an expected annualized return of 1%.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:603392•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Beijing Wantai Biological Pharmacy Enterprise publishes news
Free account required • Unsubscribe anytime